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Background
Although the cGMP-dependent protein kinase type I
(cGKI) is an important mediator of cGMP signaling in
many cells and tissues, its’ in vivo-biochemistry is not well
understood. It has been shown that the purified enzyme
can autophosphorylate multiple sites in its N-terminal
region in the presence of ATP and cyclic nucleotides
(cGMP and/or cAMP). N-terminal autophosphorylation
might be involved in the activation of the kinase by cGMP
in vitro, but it is not clear whether or not this also happens
in intact cells [1].
Results
To detect autophosphorylated cGKI in cells and tissues, we
have generated polyclonal rabbit antisera against the major
in vitro autophosphorylation sites of murine cGKI-alpha
(Ser-50; Thr-58, Ser-72, and Thr-84) and cGKI-beta (Thr-
56, Ser-63, and Ser-79). ELISAs with peptides containing
the respective amino acids in their non-phosphorylated or
phosphorylated form as well as Western blots with purified
cGKI-alpha and cGKI-beta indicated that the antisera spe-
cifically recognized the autophosphorylated N-termini of
these isoforms. The sensitivity of detection was comparable
to a highly sensitive pan-cGKI antiserum. Interestingly,
the addition of ATP (100 µM) alone was sufficient to
induce autophosphorylation of the purified isozymes in
vitro. Surprisingly, we were not able to detect phospho-
cGKI species in intact fibroblasts and vascular smooth
muscle cells, both under basal conditions as well as after
induction of cGKI kinase activity (monitored as VASP
phosphorylation) with cGMP-elevating compounds.
Conclusion
We have generated phospho-specific antisera against the
N-terminal regions of cGKI-alpha and cGKI-beta and
could confirm the previously reported autophosphoryla-
tion of these isozymes in vitro. However, our results
question the relevance of N-terminal autophosphoryla-
tion of cGKI in intact cells.
Authors’ details
1Interfakultäres Institut für Biochemie, University of Tübingen, Tübingen,
Germany. 2German Center for Neurodegenerative Diseases (DZNE),
Tübingen, Germany. 3Graduate School of Cellular & Molecular Neuroscience,
University of Tübingen, Tübingen, Germany.
Published: 29 August 2013
Reference
1. Francis SH, Busch JL, Corbin JD: cGMP-dependent protein kinases and
cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol
Rev 2010, 62:525-563.
doi:10.1186/2050-6511-14-S1-P74
Cite this article as: Vallur et al.: Phospho-specific antisera to monitor
N-terminal autophosphorylation of cGMP-dependent protein kinase
type I. BMC Pharmacology and Toxicology 2013 14(Suppl 1):P74.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: bioversatile007@gmail.com
1Interfakultäres Institut für Biochemie, University of Tübingen, Tübingen,
Germany
Full list of author information is available at the end of the article
Vallur et al. BMC Pharmacology and Toxicology 2013, 14(Suppl 1):P74
http://www.biomedcentral.com/2050-6511/14/S1/P74
© 2013 Vallur et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
